In a surprise move announced today, Behemoth Pharmaceutical has hired Charlie Weis, former Notre Dame football coach, to be CEO.
“We needed some fresh leadership around here, and Charlie Weis, with his background in sports metaphors, seemed like the ideal choice,” stated Frank Gipper, current Chairman of the Board. “When he came and spoke to us about his vision for a winning healthcare company, we just knew that he could come on board and help us execute.”
According to Weis, “It’s a real battle out there, but the Behemoth team is clearly ready to play, and we’re just going to take it one molecule at a time. We’re not going to leave anything in the labs, but we’re going to lace it up and run the best discovery program we can. I’m pumped about our beta blockers, and also that product safety I’ve been hearing about. We might even get a few small-pharma transfers to beef up our offensive pipeline.
“On paper we’re as good as any of the other guys. Right now, it just comes down to blocking and tackling. Or dosing and titrating, or whatever it is we do. We’re going to put on a clinic with our clinical trials and stay focused, remembering that there is no “I” in TEAM.”
Behemoth staffers seemed cautiously excited about Weis, feeling the momentum shift as the home team lined up for the kickoff of the new leadership group. “It’s been a real pressure cooker here, but this was a gutsy hire, and it could mark the turning point for our company,” declared Sam Biotic, VP of Sales. “Some of our mature products are in a fourth-and-long situation, but we’re tossing our old game plan out the window, we’re going to fight it out in the trenches, and we intend to put some market share points up on the board.”
Others were not impressed. J.P. MacRost, Litigation Consultant and Pharmaceutical Marketing Expert Witness, said, “Hey…I’m supposed to be the big whistleblower around here. Where does this executive jock wannabe get off thinking he can call the shots? Has he ever testified before the Swedish Congress? Besides, he looks like he needs a serious jolt of Alli or something.”
In compensation for Weis, Notre Dame will receive a VP of Finance and a diuretic to be named later.
—><—
The Pharma Side
Copyright 2007 Impactiviti LLC
Leave a Reply